The integration of chemistry and biology offers a new paradigm for accelerating drug discovery. This book explores the burgeoning field of chemogenomics, which merges combinatorial chemistry with genomics and proteomics to streamline the early stages of drug development. It provides a comprehensive overview from target selection to the design of compound libraries and lead optimization, drawing on the collective expertise of researchers from both academic institutions and major pharmaceutical companies.

The book is presented as a vital resource for drug developers and medicinal chemists, highlighting its comprehensive coverage of chemogenomics in drug discovery. Its strength lies in the synthesis of expertise from numerous research groups, aiming to provide practical applications for accelerating the discovery process. The content is structured to guide readers through the critical early stages of pharmaceutical research.